Cargando…

CrebH protects against liver injury associated with colonic inflammation via modulation of exosomal miRNA

BACKGROUND: Hepatic liver disease, including primary sclerosing cholangitis (PSC), is a serious extraintestinal manifestations of colonic inflammation. Cyclic adenosine monophosphate (cAMP)-responsive element-binding protein H (CrebH) is a transcription factor expressed mostly in the liver and small...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sang-Hee, Moon, Sung-Je, Woo, Seung Hee, Ahn, Gwangsook, Kim, Won Kon, Lee, Chul-Ho, Hwang, Jung Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304376/
https://www.ncbi.nlm.nih.gov/pubmed/37370191
http://dx.doi.org/10.1186/s13578-023-01065-9
_version_ 1785065492149436416
author Lee, Sang-Hee
Moon, Sung-Je
Woo, Seung Hee
Ahn, Gwangsook
Kim, Won Kon
Lee, Chul-Ho
Hwang, Jung Hwan
author_facet Lee, Sang-Hee
Moon, Sung-Je
Woo, Seung Hee
Ahn, Gwangsook
Kim, Won Kon
Lee, Chul-Ho
Hwang, Jung Hwan
author_sort Lee, Sang-Hee
collection PubMed
description BACKGROUND: Hepatic liver disease, including primary sclerosing cholangitis (PSC), is a serious extraintestinal manifestations of colonic inflammation. Cyclic adenosine monophosphate (cAMP)-responsive element-binding protein H (CrebH) is a transcription factor expressed mostly in the liver and small intestine. However, CrebH’s roles in the gut–liver axis remain unknown. METHODS: Inflammatory bowel disease (IBD) and PSC disease models were established in wild-type and CrebH(−/−) mice treated with dextran sulfate sodium, dinitrobenzene sulfonic acid, and diethoxycarbonyl dihydrocollidine diet, respectively. RNA sequencing were conducted to investigate differential gene expression. Exosomes were isolated from plasma and culture media. miRNA expression profiling was performed using the NanoString nCounter Mouse miRNA Panel. Effects of miR-29a-3p on adhesion molecule expression were investigated in bEnd.3 brain endothelial cells. RESULTS: CrebH(−/−) mice exhibited accelerated liver injury without substantial differences in the gut after administration of dextran sulfate sodium (DSS), and had similar features to PSC, including enlarged bile ducts, enhanced inflammation, and aberrant MAdCAM-1 expression. Furthermore, RNA-sequencing analysis showed that differentially expressed genes in the liver of CrebH(−/−) mice after DSS overlapped significantly with genes changed in PSC-liver. Analysis of plasma exosome miRNA isolated from WT and CrebH(−/−) mice indicates that CrebH can contribute to the exosomal miRNA profile. We also identified miR-29a-3p as an effective mediator for MAdCAM-1 expression. Administration of plasma exosome from CrebH(−/−) mice led to prominent inflammatory signals in the liver of WT mice with inflammatory bowel disease (IBD). CONCLUSIONS: CrebH deficiency led to increased susceptibility to IBD-induced liver diseases via enhanced expression of adhesion molecules and concomitant infiltration of T lymphocytes. Exosomes can contribute to the progression of IBD-induced liver injury in CrebH(−/−) mice. These study provide novel insights into the role of CrebH in IBD-induced liver injury. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13578-023-01065-9.
format Online
Article
Text
id pubmed-10304376
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103043762023-06-29 CrebH protects against liver injury associated with colonic inflammation via modulation of exosomal miRNA Lee, Sang-Hee Moon, Sung-Je Woo, Seung Hee Ahn, Gwangsook Kim, Won Kon Lee, Chul-Ho Hwang, Jung Hwan Cell Biosci Research BACKGROUND: Hepatic liver disease, including primary sclerosing cholangitis (PSC), is a serious extraintestinal manifestations of colonic inflammation. Cyclic adenosine monophosphate (cAMP)-responsive element-binding protein H (CrebH) is a transcription factor expressed mostly in the liver and small intestine. However, CrebH’s roles in the gut–liver axis remain unknown. METHODS: Inflammatory bowel disease (IBD) and PSC disease models were established in wild-type and CrebH(−/−) mice treated with dextran sulfate sodium, dinitrobenzene sulfonic acid, and diethoxycarbonyl dihydrocollidine diet, respectively. RNA sequencing were conducted to investigate differential gene expression. Exosomes were isolated from plasma and culture media. miRNA expression profiling was performed using the NanoString nCounter Mouse miRNA Panel. Effects of miR-29a-3p on adhesion molecule expression were investigated in bEnd.3 brain endothelial cells. RESULTS: CrebH(−/−) mice exhibited accelerated liver injury without substantial differences in the gut after administration of dextran sulfate sodium (DSS), and had similar features to PSC, including enlarged bile ducts, enhanced inflammation, and aberrant MAdCAM-1 expression. Furthermore, RNA-sequencing analysis showed that differentially expressed genes in the liver of CrebH(−/−) mice after DSS overlapped significantly with genes changed in PSC-liver. Analysis of plasma exosome miRNA isolated from WT and CrebH(−/−) mice indicates that CrebH can contribute to the exosomal miRNA profile. We also identified miR-29a-3p as an effective mediator for MAdCAM-1 expression. Administration of plasma exosome from CrebH(−/−) mice led to prominent inflammatory signals in the liver of WT mice with inflammatory bowel disease (IBD). CONCLUSIONS: CrebH deficiency led to increased susceptibility to IBD-induced liver diseases via enhanced expression of adhesion molecules and concomitant infiltration of T lymphocytes. Exosomes can contribute to the progression of IBD-induced liver injury in CrebH(−/−) mice. These study provide novel insights into the role of CrebH in IBD-induced liver injury. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13578-023-01065-9. BioMed Central 2023-06-27 /pmc/articles/PMC10304376/ /pubmed/37370191 http://dx.doi.org/10.1186/s13578-023-01065-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lee, Sang-Hee
Moon, Sung-Je
Woo, Seung Hee
Ahn, Gwangsook
Kim, Won Kon
Lee, Chul-Ho
Hwang, Jung Hwan
CrebH protects against liver injury associated with colonic inflammation via modulation of exosomal miRNA
title CrebH protects against liver injury associated with colonic inflammation via modulation of exosomal miRNA
title_full CrebH protects against liver injury associated with colonic inflammation via modulation of exosomal miRNA
title_fullStr CrebH protects against liver injury associated with colonic inflammation via modulation of exosomal miRNA
title_full_unstemmed CrebH protects against liver injury associated with colonic inflammation via modulation of exosomal miRNA
title_short CrebH protects against liver injury associated with colonic inflammation via modulation of exosomal miRNA
title_sort crebh protects against liver injury associated with colonic inflammation via modulation of exosomal mirna
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304376/
https://www.ncbi.nlm.nih.gov/pubmed/37370191
http://dx.doi.org/10.1186/s13578-023-01065-9
work_keys_str_mv AT leesanghee crebhprotectsagainstliverinjuryassociatedwithcolonicinflammationviamodulationofexosomalmirna
AT moonsungje crebhprotectsagainstliverinjuryassociatedwithcolonicinflammationviamodulationofexosomalmirna
AT wooseunghee crebhprotectsagainstliverinjuryassociatedwithcolonicinflammationviamodulationofexosomalmirna
AT ahngwangsook crebhprotectsagainstliverinjuryassociatedwithcolonicinflammationviamodulationofexosomalmirna
AT kimwonkon crebhprotectsagainstliverinjuryassociatedwithcolonicinflammationviamodulationofexosomalmirna
AT leechulho crebhprotectsagainstliverinjuryassociatedwithcolonicinflammationviamodulationofexosomalmirna
AT hwangjunghwan crebhprotectsagainstliverinjuryassociatedwithcolonicinflammationviamodulationofexosomalmirna